Artificial Intelligence is no longer a pilot project or a future ambition for banks. It is the engine running their fraud systems, the intelligence behind their customer conversations, the analyst ...
REGENXBIO Inc. announced positive topline and interim functional data from the pivotal Phase III portion of the Phase I/II/III AFFINITY DUCHENNE® trial of RGX-202, a potential best-in-class gene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results